135 related articles for article (PubMed ID: 36514670)
21. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy.
Moretti VM; Crawford EA; Staddon AP; Lackman RD; Ogilvie CM
Am J Clin Oncol; 2011 Aug; 34(4):417-21. PubMed ID: 20838322
[TBL] [Abstract][Full Text] [Related]
22. Malignant Peripheral Nerve Sheath Scalp Tumor: A Short-Term Institutional Experience with Literature Review.
Jha VC; Alam MS; Sinha VS
Asian J Neurosurg; 2023 Mar; 18(1):157-164. PubMed ID: 37056889
[TBL] [Abstract][Full Text] [Related]
23. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
24. Systemic Options for Malignant Peripheral Nerve Sheath Tumors.
Hassan A; Pestana RC; Parkes A
Curr Treat Options Oncol; 2021 Feb; 22(4):33. PubMed ID: 33641042
[TBL] [Abstract][Full Text] [Related]
25. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
26. Successful treatment with doxorubicin and ifosfamide for mediastinal malignant peripheral nerve sheath tumor with loss of H3K27me3 expression.
Seno N; Fukushima T; Gomi D; Kobayashi T; Sekiguchi N; Matsushita H; Ozawa T; Tsukahara Y; Mamiya K; Koizumi T; Sano K
Thorac Cancer; 2017 Nov; 8(6):720-723. PubMed ID: 28876532
[TBL] [Abstract][Full Text] [Related]
27. Successful Management of Intrathoracic Phrenic Malignant Peripheral Nerve Sheath Tumor by Multimodal Treatment.
Rais G; Maidi M; Rais F
J Med Cases; 2020 May; 11(5):120-124. PubMed ID: 34434380
[TBL] [Abstract][Full Text] [Related]
28. Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
van Noesel MM; Orbach D; Brennan B; Kelsey A; Zanetti I; de Salvo GL; Gaze MN; Craigie RJ; McHugh K; Francotte N; Collini P; Bisogno G; Casanova M; Ferrari A
Pediatr Blood Cancer; 2019 Oct; 66(10):e27833. PubMed ID: 31241238
[TBL] [Abstract][Full Text] [Related]
29. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
30. Malignant peripheral nerve sheath tumors of the eighth cranial nerve arising without prior irradiation.
Carlson ML; Jacob JT; Habermann EB; Glasgow AE; Raghunathan A; Link MJ
J Neurosurg; 2016 Nov; 125(5):1120-1129. PubMed ID: 26745487
[TBL] [Abstract][Full Text] [Related]
31. A malignant peripheral nerve sheath tumor of the mediastinum in a patient with neurofibromatosis type 1: report of a case.
Kawachi R; Takei H; Furuyashiki G; Koshi-Ishi Y; Goya T
Surg Today; 2008; 38(10):945-7. PubMed ID: 18820872
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Bcl-xL by ABT-737 enhances chemotherapy sensitivity in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumor cells.
Lee SJ; Park HJ; Kim YH; Kim BY; Jin HS; Kim HJ; Han JH; Yim H; Jeong SY
Int J Mol Med; 2012 Aug; 30(2):443-50. PubMed ID: 22664653
[TBL] [Abstract][Full Text] [Related]
33. Malignant peripheral nerve sheath tumor of the maxilla: Case report and review of the literature with emphasis on its poor prognosis.
Oh KY; Hong SD
Oral Oncol; 2022 Dec; 135():106211. PubMed ID: 36257181
[TBL] [Abstract][Full Text] [Related]
34. Schwann cell lines derived from malignant peripheral nerve sheath tumors respond abnormally to platelet-derived growth factor-BB.
Dang I; DeVries GH
J Neurosci Res; 2005 Feb; 79(3):318-28. PubMed ID: 15602756
[TBL] [Abstract][Full Text] [Related]
35. Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.
Alewine G; Knight J; Ghantae A; Mamrega C; Attiah B; Coover RA; Fahrenholtz CD
J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887576
[TBL] [Abstract][Full Text] [Related]
36. A giant posterior mediastinal malignant peripheral nerve sheath tumor and benign neurofibroma in body surface: a case report.
Zhang Y; Cai H; Lv G; Li Y
BMC Surg; 2021 Mar; 21(1):128. PubMed ID: 33691671
[TBL] [Abstract][Full Text] [Related]
37. Radiological findings of malignant peripheral nerve sheath tumor: reports of six cases and review of literature.
Yu YH; Wu JT; Ye J; Chen MX
World J Surg Oncol; 2016 May; 14():142. PubMed ID: 27159980
[TBL] [Abstract][Full Text] [Related]
38. Intrathoracic Malignant Peripheral Nerve Sheath Tumor: Histopathological and Immunohistochemical Features.
Ralli M; Singh S; Hasija S; Verma R
Iran J Pathol; 2015; 10(1):74-8. PubMed ID: 26516330
[TBL] [Abstract][Full Text] [Related]
39. Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study.
Martin E; Coert JH; Flucke UE; Slooff WM; van de Sande MAJ; van Noesel MM; Grünhagen DJ; Wijnen MHWA; Verhoef C
Pediatr Blood Cancer; 2020 Apr; 67(4):e28138. PubMed ID: 31889416
[TBL] [Abstract][Full Text] [Related]
40. Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.
Friedrich RE; Hartmann M; Mautner VF
Anticancer Res; 2007; 27(4A):1957-60. PubMed ID: 17649804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
